(Q51933184)

17 April 2018

title

Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios. (English)

1 reference

17 April 2018

main subject

phase II clinical trial

0 references

phase I clinical trial

0 references

author name string

Guosheng Yin

series ordinal

1

1 reference

17 April 2018

Yisheng Li

series ordinal

2

1 reference

17 April 2018

Yuan Ji

series ordinal

3

1 reference

17 April 2018

language of work or name

English

0 references

publication date

1 September 2006

1 reference

17 April 2018

published in

Biometrics

1 reference

17 April 2018

volume

62

1 reference

17 April 2018

issue

3

1 reference

17 April 2018

page(s)

777-784

1 reference

17 April 2018

maintained by WikiProject

WikiProject Mathematics

0 references

cites work

A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

The bivariate continual reassessment method. extending the CRM to phase I trials of two competing outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

On the use of nonparametric curves in phase I trials with low toxicity tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

A curve-free method for phase I clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

Adaptive Rejection Metropolis Sampling within Gibbs Sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

Some practical improvements in the continual reassessment method for phase I studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

A comparison of two phase I trial designs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

Bayesian nonparametric inference on the dose level with specified response rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

Continual reassessment method: a likelihood approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

Design and analysis of phase I clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

Dose-finding based on efficacy-toxicity trade-offs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2006.00534.X

10.1111/J.1541-0420.2006.00534.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018